Impact of a Community-Based Weight Loss Program on Renal Function

被引:0
作者
Schwasinger-Schmidt, Tiffany E. [1 ]
Elhomsy, Georges [1 ]
Paull-Forney, Bobbie G. [2 ]
机构
[1] Kansas Univ, Sch Med Wichita, Internal Med, Wichita, KS 67214 USA
[2] Ascens Via Christi Hosp, Weight Management Clin, Wichita, KS USA
关键词
obesity; kidney function; weight loss; lifestyle intervention; improved ckd stage; behavioral change in weight loss; nutrition and metabolism; diabetes mellitus; hypertension; community based weight loss intervention; CHRONIC KIDNEY-DISEASE; BODY-MASS INDEX; METABOLIC SYNDROME; OBESITY; RISK;
D O I
10.7759/cureus.8101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Obesity is associated with increased morbidity and mortality and is an independent risk factor for the development and progression of chronic kidney disease (CKD). This study investigated the effect of a community-based, lifestyle-focused, weight-loss intervention on renal function among participants at baseline following 12 weeks of therapy. Methods A retrospective analysis of adults enrolled in a weight management program from 2009 to 2014 was conducted. Participants consumed at least 800 kilocalories per day in meal replacements, attended weekly behavioral education classes, and expended approximately 300 kilocalories per day in physical activity. The primary outcome was the association of weight loss and changes in glomerular filtration rate (GFR). Secondary outcomes included changes in blood sugar levels, lipid parameters, blood pressure, and the use of medication for hypertension and diabetes mellitus. Results Of the 71 participants, 63.4% were female, the average weight was 289 pounds, the average body mass index (BMI) of 53, and baseline GFR 47 ml/min/1.73m(2). Following 12 weeks of the intervention, 76.1% of participants improved in CKD stage, 22.4% remained within the same stage, and 1.5% progressed to a higher stage (3A to 3B). Analysis revealed a correlation between weight loss and improved GFR (p=0.0006). Improvements were noted in blood sugar levels, blood pressure, and lipids (p<0.05). Medications were reduced in 61.8% of participants for hypertension and 83.3% for diabetes. Conclusions A significant correlation was observed between weight loss and improved renal function, with most participants improving in CKD stage. Participants also improved in markers of chronic disease and required fewer medications. When controlling for both diabetes and hypertension, the effect of improved renal function persisted.
引用
收藏
页数:15
相关论文
共 28 条
[1]  
[Anonymous], 2020, CLASSIFY CKD
[2]  
[Anonymous], 2020, WHO FACT SHEET OBESI
[3]   Effects of weight loss on renal function in obese CKD patients: a systematic review [J].
Bolignano, Davide ;
Zoccali, Carmine .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 :82-98
[4]   The effects of weight loss on renal function in patients with severe obesity [J].
Chagnac, A ;
Weinstein, T ;
Herman, M ;
Hirsh, J ;
Gafter, U ;
Ori, Y .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (06) :1480-1486
[5]   Cardiovascular and Renal Effects of Weight Reduction in Obesity and the Metabolic Syndrome [J].
Cohen, Jordana B. ;
Cohen, Debbie L. .
CURRENT HYPERTENSION REPORTS, 2015, 17 (05)
[6]   Obesity and target organ damage: the kidney [J].
de Jong, PE ;
Verhave, JC ;
Pinto-Sietsma, SJ ;
Hillege, HL .
INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (Suppl 4) :S21-S24
[7]  
Demaria E., 2018, SURG OBES RELAT DIS, V14, pS71, DOI [10.1016/j.soard.2018.09.115, DOI 10.1016/J.SOARD.2018.09.115]
[8]   Obesity, diabetes, and chronic kidney disease [J].
Eknoyan G. .
Current Diabetes Reports, 2007, 7 (6) :449-453
[9]  
Felizardo Raphael Jose Ferreira, 2014, World J Nephrol, V3, P50, DOI 10.5527/wjn.v3.i3.50
[10]   Weighing the evidence: obesity, metabolic syndrome, and the risk of chronic kidney disease [J].
Gabbay, Ezra ;
Slotki, Itzchak ;
Shavit, Linda .
BMC NEPHROLOGY, 2015, 16